Masahito Yamada

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 339 publications

Diverging Clinical and Amyloid Positron Emission Tomography Features in Iatrogenic Cerebral Amyloid Angiopathy.

Diverging Clinical and Amyloid Positron Emission Tomography Features in Iatrogenic Cerebral Amyloid Angiopathy.

Journal: Clinical nuclear medicine
Published: April 22, 2026

Multidisciplinary recommendations for palliative and supportive care in Creutzfeldt-Jakob disease and related disorders.

Multidisciplinary recommendations for palliative and supportive care in Creutzfeldt-Jakob disease and related disorders.

Journal: Age and ageing
Published: April 13, 2026

Classification of sporadic Creutzfeldt-Jakob disease based on resting state scalp-recorded electroencephalogram-derived indices.

Classification of sporadic Creutzfeldt-Jakob disease based on resting state scalp-recorded electroencephalogram-derived indices.

Journal: PloS one
Published: March 24, 2026

Prospective study on clinical utility of plasma p-Tau217 and other biomarkers in Japanese memory clinics using the LUMIPULSE platform.

Prospective study on clinical utility of plasma p-Tau217 and other biomarkers in Japanese memory clinics using the LUMIPULSE platform.

Journal: Alzheimer's research & therapy
Published: November 14, 2025

Retraction notice to "α-Lipoic acid exhibits anti-amyloidogenicity for β-amyloid fibrils in vitro" [Biochem. Biophys. Res. Commun. 341 (2006) 1046-1052].

Retraction notice to "α-Lipoic acid exhibits anti-amyloidogenicity for β-amyloid fibrils in vitro" [Biochem. Biophys. Res. Commun. 341 (2006) 1046-1052].

Journal: Biochemical and biophysical research communications
Published: October 12, 2025

Retraction Notice to "Cerebrospinal fluid of Alzheimer patients promotes β-amyloid fibril formation in vitro" [Neurobiology of Disease 20 (2005) 233-240].

Retraction Notice to "Cerebrospinal fluid of Alzheimer patients promotes β-amyloid fibril formation in vitro" [Neurobiology of Disease 20 (2005) 233-240].

Journal: Neurobiology of disease
Published: September 12, 2025

Retraction Notice to "Cerebrospinal fluid of Alzheimer's disease and dementia with Lewy bodies patients enhances -synuclein fibril formation in vitro" [Experimental Neurology 203 (2007) 579-583].

Retraction Notice to "Cerebrospinal fluid of Alzheimer's disease and dementia with Lewy bodies patients enhances -synuclein fibril formation in vitro" [Experimental Neurology 203 (2007) 579-583].

Journal: Experimental neurology
Published: September 11, 2025

Natalizumab-Associated Progressive Multifocal Leukoencephalopathy After Natalizumab Extended Interval Dosing Therapy in Japan.

Natalizumab-Associated Progressive Multifocal Leukoencephalopathy After Natalizumab Extended Interval Dosing Therapy in Japan.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: August 28, 2025

Comparison of MRI-, CT- and PET-based anatomical standardization for Centiloid scale calculation in [18F]florbetapir positron emission tomography.

Comparison of MRI-, CT- and PET-based anatomical standardization for Centiloid scale calculation in [18F]florbetapir positron emission tomography.

Journal: Annals of nuclear medicine
Published: May 06, 2025

A noninvasive test for human prion disease using hair roots and scalp.

A noninvasive test for human prion disease using hair roots and scalp.

Journal: Scientific reports
Published: January 27, 2025

A Retrospective Cohort Study of a Newly Proposed Criteria for Sporadic Creutzfeldt-Jakob Disease.

A Retrospective Cohort Study of a Newly Proposed Criteria for Sporadic Creutzfeldt-Jakob Disease.

Journal: Diagnostics (Basel, Switzerland)
Published: September 13, 2024

Neuropathology of Disorders Leading to Dementia

Neuropathology of Disorders Leading to Dementia

Journal: Brain and nerve = Shinkei kenkyu no shinpo
Published: April 08, 2024
Showing 1-12 of 339

Last Updated: 09/26/2026